EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban

Hamin Kim, Tae-Jin Song iD, Jeong Yee, Dong-Hyeok Kim, Junbeom Park iD, Hye Sun Gwak iD

Drug Design, Development and Therapy · 2023-08 · Volume 17 · 2513-2522

DOI: 10.2147/dddt.s417096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023-08. Verfasst von Hamin Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea. Hauptthemen laut MEDLINE: Rivaroxaban, Neoplasm Proteins. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RivaroxabanNeoplasm ProteinsMaleHumansAgedFemaleATP Binding Cassette Transporter, Subfamily G, Member 2Case-Control StudiesPolymorphism, Single NucleotidePyrazolesPyridones

Stichwörter der Autor:innen

ABCG2apixabanbleeding complicationspolymorphismrivaroxaban

Substanzen

RivaroxabanATP Binding Cassette Transporter, Subfamily G, Member 2Neoplasm ProteinsapixabanPyrazolesPyridonesABCG2 protein, human

Autor:innen und Institutionen

  • College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea.
  • Department of Neurology, Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
  • Department of Cardiology, Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
  • Department of Cardiology, Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.

ORCID-Profile: Tae-Jin Song, Junbeom Park, Hye Sun Gwak

Zitieren

APA

Kim, H., Song, T. J., Yee, J., Kim, D. H., Park, J., & Gwak, H. S. (2023). ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban. Drug Design, Development and Therapy, Volume 17, 2513-2522. https://doi.org/10.2147/dddt.s417096

Vancouver

Kim H, Song TJ, Yee J, Kim DH, Park J, Gwak HS. ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban. Drug Design, Development and Therapy. 2023;Volume 17:2513-2522. doi:10.2147/dddt.s417096

BibTeX
@article{Kim2023,
  author = {Kim, Hamin and Song, Tae-Jin and Yee, Jeong and Kim, Dong-Hyeok and Park, Junbeom and Gwak, Hye Sun},
  title = {ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  volume = {Volume 17},
  pages = {2513--2522},
  doi = {10.2147/dddt.s417096}
}
Kostenlos starten →